1. Kay E Davies is at the MRC Functional Genetics Unit, Departments of Physiology, Anatomy and Genetics, University of Oxford, Oxford OX1 3QX, UK. e-mail: Kay.davies@dpag.ox.ac.uk
2. Tejvir S Khurana is in the Department of Physiology and at the Pennsylvania Muscle Institute, University of Pennsylvania School of Medicine, Richards Building, 3700 Hamilton Walk, Philadelphia, Pennsylvania 19104, USA. e-mail: tsk@mail.med.upenn.edu

Abstract

A key regulator of the neuromuscular junction, the transcriptional co-activator PGC-1, is a potential target for Duchenne muscular dystrophy therapy.

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NPG Journals

by Subject Area

• Chemistry

  • Chemistry
  • Drug discovery
  • Biotechnology
  • Materials
  • Methods & Protocols

• Clinical Practice & Research

  • Cancer
  • Cardiovascular medicine
  • Dentistry
  • Endocrinology
  • Gastroenterology & Hepatology
  • Methods & Protocols
  • Pathology & Pathobiology
  • Urology

• Earth & Environment

  • Earth sciences
  • Evolution & Ecology

• Life sciences

  • Biotechnology
  • Cancer
  • Development
  • Drug discovery
  • Evolution & Ecology
  • Genetics
  • Immunology
  • Medical research
  • Methods & Protocols
  • Microbiology
  • Molecular cell biology
  • Neuroscience
  • Pharmacology
  • Systems biology

• Physical sciences

  • Physics
  • Materials

by A - Z Index